↓ Skip to main content

Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision

Overview of attention for article published in BMC Gastroenterology, February 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
1 patent

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
59 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision
Published in
BMC Gastroenterology, February 2013
DOI 10.1186/1471-230x-13-36
Pubmed ID
Authors

Marisa Donada, Serena Bonin, Renzo Barbazza, Daniel Pettirosso, Giorgio Stanta

Abstract

There is uncertainty on the benefit of adjuvant chemotherapy in patients with stage II colorectal cancers. The aim of this study is to investigate the combined role of clinical, pathological and molecular parameters to identify those stage II patients who better benefit from adjuvant therapy.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 3%
Sweden 1 2%
United Kingdom 1 2%
South Africa 1 2%
Denmark 1 2%
Japan 1 2%
Unknown 52 88%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 20%
Student > Master 10 17%
Student > Ph. D. Student 7 12%
Professor > Associate Professor 6 10%
Librarian 3 5%
Other 11 19%
Unknown 10 17%
Readers by discipline Count As %
Medicine and Dentistry 30 51%
Agricultural and Biological Sciences 7 12%
Biochemistry, Genetics and Molecular Biology 3 5%
Computer Science 2 3%
Immunology and Microbiology 2 3%
Other 4 7%
Unknown 11 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 January 2018.
All research outputs
#7,432,447
of 22,721,584 outputs
Outputs from BMC Gastroenterology
#468
of 1,732 outputs
Outputs of similar age
#64,331
of 192,990 outputs
Outputs of similar age from BMC Gastroenterology
#13
of 29 outputs
Altmetric has tracked 22,721,584 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,732 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,990 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.